The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm

BACKGROUND: Coronary vasospasm is a known side effect of 5-FU (fluorouracil) therapy. Beyond switching to non-5FU-based chemotherapy, there are no established treatments for 5-FU associated coronary vasospam. Our objective was to assess the safety and efficacy of re-challenge with 5-FU after pre-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafar, Amna, Drobni, Zsofia D., Lei, Matthew, Gongora, Carlos A., Quinaglia, Thiago, Lou, Uvette Y., Mosarla, Ramya, Murphy, Sean P., Jones-O’Connor, Maeve, Mahmood, Ali, Hartmann, Sarah, Gilman, Hannah K., Weekes, Colin D., Nipp, Ryan, Clark, John R., Clark, Jeffrey W., Blaszkowsky, Lawrence S., Tavares, Erica, Neilan, Tomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989300/
https://www.ncbi.nlm.nih.gov/pubmed/35390017
http://dx.doi.org/10.1371/journal.pone.0265767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989300/
https://www.ncbi.nlm.nih.gov/pubmed/35390017
http://dx.doi.org/10.1371/journal.pone.0265767

Ejemplares similares